【ChiCTR2000029016】Enhancing Family Wellness through Parallel Parent–Child Mindfulness Intervention in Migrant Communities
ChiCTR2000029016
尚未开始
/
/
/
2020-01-11
/
/
parental stress, family function
Enhancing Family Wellness through Parallel Parent–Child Mindfulness Intervention in Migrant Communities
Enhancing Family Wellness through Parallel Parent–Child Mindfulness Intervention in Migrant Communities
(1) To examine the effectiveness of a parallel mindfulness parent-child intervention on parenting stress, parental interpersonal mindfulness, child mindfulness, and family functioning among low-income rural-to-urban migrant families; (2) To empower community organizations to use evidence-based interventions to work with the under-served migrant families.
随机平行对照
探索性研究/预试验
A research assistant will use a computerized randomization program to allocate participants to intervention and wait-list control groups on a 1:1 ratio.
Open label
Knowledge Exchange (KE) Funding
/
30
/
2019-09-01
2020-07-31
/
Migrant parents (either father or mother) without official Shenzhen residency, and their children aged 9-12 years；
请登录查看exclude children and parents who have a clinical diagnosis of severe mental illness, or children with special education needs (e.g. ADHD, Autism Spectrum Disorder, learning disabilities)；
请登录查看香港大學
/
香港大學的其他临床试验
- 腦部直流電剌激於增強認知訓練成效的研究
- A randomised controlled trial on effects of a home-based exercise programme incorporating mindfulness and yoga practice on motor symptoms for people with Parkinson’s Disease
- Randomized controlled trial of Enhancing Contact Model on reducing stigma of mental illness in family caregivers of persons with schizophrenia in rural China
- Effects of a live streaming Mindfulness Yoga - Practice Awareness through Cognitive-based Exercise (MY-PACE) Program on balance and gait for People with Parkinson’s Disease: A Randomised Controlled Trial
- Enhancing Family Wellness through Parallel Parent–Child Mindfulness Intervention in Migrant Communities
- Recovery-oriented cognitive-behaviour approach for people with schizophrenia in Hong Kong
- 中国南方地区的耐药性真菌病原体的出现和流行性分析
- 益生菌作爲牙周病輔助治療
香港大學社會工作和社會管理系的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04